Fingerprint
Dive into the research topics where Dongfeng Tan is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Should I Admire the Cecum for a While Once I Get There? A Trilogy
Bhutani, M. S., Tan, D. & Mansfield, P. F., Jan 2026, In: Gastro Hep Advances. 5, 5, 100909.Research output: Contribution to journal › Article › peer-review
Open Access -
Diverticulitis Post Immune Checkpoint Inhibitor Therapy
Thomas, A. R., Lu, Y., Nahmod, K. A., Tan, D., Altan, M., Shafi, M. A. & Wang, Y., Jan 1 2025, Challenging Cases in Immunotherapy Related Organ Toxicities. Springer Science+Business Media, p. 119-124 6 p.Research output: Chapter in Book/Report/Conference proceeding › Chapter
-
Genomic landscape and potential therapeutic targets in alpha-fetoprotein-producing gastric cancer
Zan, L., Zhang, X., Shen, L., Zhao, Q., Tan, D., Peng, X., Jia, Y., Li, J., Liu, J., Zhao, J., Gao, N., Bu, P. & Xi, Y., May 2025, In: Gastric Cancer. 28, 3, p. 372-383 12 p., 103841.Research output: Contribution to journal › Article › peer-review
Open Access4 Link opens in a new tab Scopus citations -
Immune Checkpoint Inhibitor–Induced Colitis
S. Thomas, A., Lu, Y., Campbell, M., Thompson, J. A., Tan, D., Faleck, D. M. & Wang, Y., Jan 2025, In: Gastroenterology. 168, 1, p. 21-28 8 p.Research output: Contribution to journal › Comment/debate › peer-review
Open Access2 Link opens in a new tab Scopus citations -
Sclerosing Mesenteritis After Immune Checkpoint Inhibitor Therapy
Kuang, A. G., Lu, Y., Tan, D., Shatila, M., Wang, Y. & Thompson, J. A., Jan 1 2025, Challenging Cases in Immunotherapy Related Organ Toxicities. Springer Science+Business Media, p. 135-141 7 p.Research output: Chapter in Book/Report/Conference proceeding › Chapter